56 Improvement of prognosis irrespective of age in early node negative early breast cancer by adjuvant high-dose medroxyprogesterone acetate (HD-MPA); ten years results of a multicenter randomized trial

European Journal of Cancer ◽

10.1016/0959-8049(95)95308-s ◽

1995 ◽

Vol 31 ◽

pp. S13

Author(s):

C. Focan ◽

M. Beauduin ◽

E. Salamon ◽

J. de Grève ◽

G. de Wasch ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Early Breast Cancer ◽

Medroxyprogesterone Acetate ◽

High Dose ◽

Node Negative ◽

Multicenter Randomized Trial

Download Full-text

High-Dose Medroxyprogesterone Acetate as Adjuvant Hormonotherapy in Early Breast Cancer: 9 Years Results of a Multicenter Randomized Trial

Contributions to Oncology - Hormone-Dependent Tumors ◽

10.1159/000424683 ◽

1995 ◽

pp. 145-158

Author(s):

C. Focan ◽

M. Beauduin ◽

E. Salamon ◽

J. De Greve ◽

G. De Wasch ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Early Breast Cancer ◽

Medroxyprogesterone Acetate ◽

High Dose ◽

Multicenter Randomized Trial

Download Full-text

Adjuvant Treatment with High Dose Medroxyprogesterone Acetate in Node-Negative Early Breast Cancer A 3-year Interim Report on a Randomized Trial (I)

Acta Oncologica ◽

10.3109/02841868909111254 ◽

1989 ◽

Vol 28 (2) ◽

pp. 237-240 ◽

Cited By ~ 5

Author(s):

C. Focan ◽

A. Baudoux ◽

M. Beauduin ◽

U. Bunescu ◽

N. Dehasque ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Medroxyprogesterone Acetate ◽

High Dose ◽

Interim Report ◽

Node Negative

Download Full-text

P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial

European Journal of Cancer ◽

10.1016/s0959-8049(97)89319-7 ◽

1998 ◽

Vol 34 ◽

pp. S40

Author(s):

C. Focan ◽

M. Beauduin ◽

E. Salamon ◽

J. de Greve ◽

G. de Wasch ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Early Breast Cancer ◽

Medroxyprogesterone Acetate ◽

High Dose ◽

Multicenter Randomized Trial

Download Full-text

High-Dose Oral Medroxyprogesterone Acetate or Tamoxifen as Adjuvant Hormone Therapy for Node-Negative Early-Stage Breast Cancer: Randomized Trial with 7-Year Update

Clinical Breast Cancer ◽

10.3816/cbc.2004.n.018 ◽

2004 ◽

Vol 5 (2) ◽

pp. 136-141 ◽

Cited By ~ 3

Author(s):

Christian Focan ◽

Marc Beauduin ◽

Françoise Majois ◽

Jean-Luc Canon ◽

Giuseppe Cusumano ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Hormone Therapy ◽

Medroxyprogesterone Acetate ◽

Early Stage ◽

Early Stage Breast Cancer ◽

High Dose ◽

Adjuvant Hormone Therapy ◽

Node Negative ◽

Dose Oral

Download Full-text

46 Unexpected opposite age related effect of adjuvant high-dose progesterone acetate (HD-MPA) for node positive (NP) early breast cancer: 10 years results of a multicenter randomized trial

European Journal of Cancer ◽

10.1016/0959-8049(95)95298-k ◽

1995 ◽

Vol 31 ◽

pp. S11

Author(s):

C. Focan ◽

M. Beauduin ◽

E. Salamon ◽

J. de Gréve ◽

G. de Wasch ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Early Breast Cancer ◽

High Dose ◽

Related Effect ◽

Node Positive ◽

Multicenter Randomized Trial ◽

Age Related

Download Full-text

Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial

British Journal of Cancer ◽

10.1054/bjoc.2001.1829 ◽

2001 ◽

Vol 85 (1) ◽

pp. 1-8 ◽

Cited By ~ 15

Author(s):

C Focan ◽

◽

M Beauduin ◽

E Salamon ◽

J de Greve ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Early Breast Cancer ◽

Medroxyprogesterone Acetate ◽

High Dose

Download Full-text

Weekly Low-Dose Doxorubicin with or Without High-Dose Medroxyprogesterone Acetate as Secondary Treatment in Metastatic Breast Cancer—A Randomized Trial

Acta Oncologica ◽

10.3109/02841868809093543 ◽

1988 ◽

Vol 27 (3) ◽

pp. 297-299 ◽

Cited By ~ 1

Author(s):

I. Elomaa ◽

C. Blomqvist ◽

P. Rissanen ◽

M. Mäntylä

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Trial ◽

Medroxyprogesterone Acetate ◽

Low Dose ◽

Metastatic Breast ◽

High Dose ◽

Secondary Treatment

Download Full-text

Medroxyprogesterone acetate high-dose (HD-MPA) vs HD-MPA plus bromocriptine (Br) in advanced breast cancer: Preliminary results of a multicentric randomized trial

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(86)90190-2 ◽

1986 ◽

Vol 22 (6) ◽

pp. 720

Author(s):

L. Dogliotti ◽

G. Robustelli della Cuna ◽

F. Di Carlo

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Medroxyprogesterone Acetate ◽

Advanced Breast ◽

High Dose ◽

Preliminary Results

Download Full-text

High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(87)90056-3 ◽

1987 ◽

Vol 23 (12) ◽

pp. 1895-1900 ◽

Cited By ~ 19

Author(s):

Christopher J. Gallagher ◽

Fiona Cairnduff ◽

Ian E. Smith

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Medroxyprogesterone Acetate ◽

Low Dose ◽

Advanced Breast ◽

High Dose

Download Full-text

535 Randomized trial of low vs. High dose medroxyprogesterone acetate (MPA) in the treatment of post-menopausal patients with advanced breast cancer

Journal of Steroid Biochemistry ◽

10.1016/0022-4731(83)92036-8 ◽

1983 ◽

Vol 19 ◽

pp. 189

Author(s):

F. Cavalli ◽

A. Goldhirsch ◽

G. Jungi ◽

G. Martz ◽

B. Mermillod ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Randomized Trial ◽

Medroxyprogesterone Acetate ◽

Advanced Breast ◽

High Dose ◽

Post Menopausal

Download Full-text